Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases.
Take a look at the 1-year chart of Intercept (NASDAQ: ICPT) with the added notations:
Over the course of the past 3 months, ICPT has formed a key level of support at $55 (red). Traders might have expected a bounce from the recent text of $55, but instead the stock has broken that support. Lower prices should be expected from here.
The Tale of the Tape: ICPT broke a key level of support at $55. A trader could enter a short position on any rallies up to or near $55 with a stop placed above the level. If the stock were to break back above the $55 level, a long position might be entered instead.
Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.
No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!
Christian Tharp, CMT